Benjamin Hickey
Affiliations
- at Mural Oncology Plc (MURA), 2025-06-13
- President, Rayzebio Org. at Bristol Myers Squibb Co (BMY), 2025-05-13
- Evp, Chief Commercial Officer at Mirati Therapeutics Inc. (MRTX), 2024-01-24
- Director at Surface Oncology Inc. (SURF), 2022-06-11
- Svp, Chief Commerical Officer at Halozyme Therapeutics Inc. (HALO), 2019-10-01
Insider Trading: Sales See All
| Symbol | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| BMY | $38.01 | 97 | $3,701.83 | 0 | 2025-05-09 | Filing |
| MRTX | $59.02 | 631 | $37,241.62 | 117,028 | 2024-01-16 | Filing |
| MRTX | $59.02 | 966 | $57,013.32 | 117,659 | 2024-01-16 | Filing |
| MRTX | $58.92 | 2,090 | $123,142.80 | 118,625 | 2024-01-08 | Filing |
| MRTX | $56.67 | 2,220 | $125,807.40 | 103,694 | 2023-12-13 | Filing |